Solventum (NYSE: SOLV) announces it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered materials for regenerative wound care. Solventum has acquired Acera for an upfront cash payment of $725 million, subject to customary purchase price adjustments, and up to $125 million in contingent cash payments based on the achievement of certain future milestones.
Read the full article: Solventum Completes Acquisition of Acera Surgical //
Source: https://www.prnewswire.com/news-releases/solventum-completes-acquisition-of-acera-surgical-302648847.html